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Protein AMPylation, the transfer of AMP from ATP to
protein targets, has been recognized as a newmech-
anism of host-cell disruption by some bacterial effec-
tors that typically contain a FIC-domain. Eukaryotic
genomes also encode one FIC-domain protein,
HYPE, which has remained poorly characterized.
Here we describe the structure of human HYPE,
solved by X-ray crystallography, representing the
first structure of a eukaryotic FIC-domain protein.
We demonstrate that HYPE forms stable dimers
with structurally and functionally integrated FIC-do-
mains and with TPR-motifs exposed for protein-pro-
tein interactions. As HYPE also uniquely possesses
a transmembrane helix, dimerization is likely to affect
its positioning and function in the membrane vicinity.
The low rate of autoAMPylation of the wild-type
HYPE could be due to autoinhibition, consistent
with the mechanism proposed for a number of puta-
tive FIC AMPylators. Our findings also provide a ba-
sis to further consider possible alternative cofactors
of HYPE and distinct modes of target-recognition.
INTRODUCTION
It is well established that posttranslational modifications (PTM) of
proteins provide a keymechanism for control of protein functional
states, protein-protein interactions, subcellular localization,
and stability (Deribe et al., 2010; Kamath et al., 2011). In addition
to the best-understood PTM, phosphorylation of proteins, several
other common modifications have been identified including
methylation, acetylation, and ubiquitination. Very recently
AMPylation of eukaryotic proteins was also documented (Yar-
brough andOrth, 2009). AMPylation (or adenylylation) is the trans-
fer of AMP from ATP to a Tyr or Thr/Ser residue in target proteins.
Most enzymes known to catalyze AMPylation are bacterial effec-
tors that are secreted into infected cells, where they AMPylate
small GTPases (Rho and Rab families), causing disruption to theStruhost cell (Mu¨ller et al., 2010; Roy andMukherjee, 2009; Yarbrough
et al., 2009). These bacterial effectors are regarded as potential
new targets in drug discovery since AMPylation plays an impor-
tant role in infection (Lewallen et al., 2014).
The majority of bacterial AMPylators incorporate a so-called
filamentation induced by cyclic AMP (FIC) domain responsible
for AMP transfer (Broncel et al., 2012; Garcia-Pino et al., 2014).
Further analysis of bacterial effectors has shown that the
cofactor specificity is not restricted to ATP, with some FIC do-
mains catalyzing GMPylation and UMPylation reactions (Feng
et al., 2012). Furthermore, FIC domains can also catalyze other
reactions instead of NMPylation, such as phosphorylation and
phosphocholine transfer (Campanacci et al., 2013; Castro-Roa
et al., 2013; Cruz et al., 2014). Nevertheless, as clearly illustrated
for phosphocholine transfer by AnkX (Campanacci et al., 2013),
the underlying reactions share a common mechanism and
involve the transfer of a part of a pyrophosphate-bond-contain-
ing metabolite and the cleavage of this bond.
The first reports of AMPylation focused on the structure and
function of bacterial FIC proteins (Campanacci et al., 2013; Engel
et al., 2012; Feng et al., 2012;Goepfert et al., 2013;HamandOrth,
2011; Mu¨ller et al., 2010; Roy and Mukherjee, 2009; Worby et al.,
2009; Xiao et al., 2010; Yarbrough et al., 2009). These data
strongly suggest that such a modification, in particular eukaryotic
AMPylation, is a reversible and regulatory PTM. However, the
scope and precise physiological relevance beyond bacterial
infection is currently largely unknown. Interestingly, in eukaryotic
genomes only one FIC-domain containing protein has been iden-
tified to date, HYPE or FICD, and it is strongly conserved from
C. elegans to humans (Yarbrough and Orth, 2009). Domain orga-
nization is also conserved and, in addition to the FIC domain, the
protein incorporates one transmembrane helix and tetratricopep-
tide repeat (TPR) motifs. However, very little is known about prop-
erties of HYPEwith regard to both structure and its function in any
of these organisms. Some initial characterizations of HYPE
suggest that its FIC domain can catalyze NMPylation, including
AMPylation (Engel et al., 2012; Mattoo et al., 2011; Worby et al.,
2009). The only functional insight has been recently obtained
from a study on Drosophila, where flies lacking HYPE were viable
and fertile, but blind due to compromised visual neurotransmis-
sion; the link between catalytic functionality of the FIC domain



























Figure 1. Crystal Structure of HYPE
(A) Schematic diagram of domain organization of
full-length human protein (top) and construct used
for crystallization (bottom).
(B) Ribbon (left) and surface (right) representation
of HYPE structure showing relative orientations of
the TPR-motifs, linker, and FIC domain. *Pocket for
cofactor binding in the FIC domain of the wild-type
structure.
See also Figures S1–S3.
Structure
Structure of HYPEHere we describe the first crystal structure of a eukaryotic
HYPE encompassing the two TPR-motifs, an a-helical linker,
and the FIC domain of the human protein. The structure and
further analyses reveal several features of HYPE that are distinct
from most previously characterized bacterial effectors and sug-
gest a different cellular function for this FIC-domain protein.
RESULTS
3D Structure of the Multidomain, Human HYPE Protein
Structural studies of HYPE were performed using a construct
lacking the first 102 amino-acid residues at theN terminus, incor-
porating a single transmembrane domain (residues 24–44). The
construct included two TPR-motifs (residues 105–135 and
140–170), a linker region (residues 170– 215), and the FIC
domain (residues 215–432) (Figure 1A). While the portion at the
N terminus shares low sequence similarity among different spe-
cies, sequences within the boundaries of the construct used for
structural studies are strongly conserved throughout its length
(51% similarity) (Figure S1 available online). Structures of several
variants of this multidomain HYPE construct were solved by
X-ray crystallography with a resolution of up to 2.5A˚ (Table 1).
As shown in Figure 1B, almost the entire structure of the HYPE
construct is composed of a helices that represent the main sec-
ondary structure element of the TPR-motifs and the FIC domain,
with the linker between them consisting of a single a helix. A sur-
face representation of the protein (Figure 1B, right) illustrates a1832 Structure 22, 1831–1843, December 2, 2014 ª2014 The Authorscompact structure with restricted flexi-
bility owing to intramolecular interactions,
where each of the three main structural
features (TPR-motifs, linker, and FIC
domain) interact with the other two.
TPR-motifs are found in a number of
different organisms (from bacteria to
humans), and the number of TPR repeats,
each consisting of two antiparallel a heli-
ces, varies (Allan and Ratajczak, 2011;
Blatch and La¨ssle, 1999; D’Andrea and
Regan, 2003; Zeytuni and Zarivach,
2012). The presence of only two TPR-mo-
tifs in HYPE is unusual; most TPR proteins
contain three or more (up to 16) TPR-mo-
tifs implicated in protein-protein interac-
tions. The only other example of two
TPR-motifs is from the propyl 4-hydroxy-
lase (P4H) a subunit (Pekkala et al.,
2004). The structure of the TPR-motifspresent in HYPE superimposes well with the structures from
P4H, as well as with the more typical three-TPR domain of pro-
tein phosphatase 5 (PP5) (Figure 2A). As in other examples, par-
allel packing of adjacent TPR-motifs generates a right-handed
helical conformation, creating a channel (or groove) that can
accommodate a polypeptide from another protein (Figure 2A).
In many cases, the TPR domains present an additional
‘‘capping/solubility’’ helix C-terminal to the TPRs. In HYPE, it is
likely that the linker a helix could have this role and could be
considered as a part of the TPR domain (Figure 2A). The initial
TPR repeat in all HYPE structures exhibits a high degree of dis-
order when compared to the rest of the structure; this is reflected
in the high thermal-factors for this region andmissing side chains
where the density is poor. Electron density is improved for the
underlying main chain positions, giving confidence in the overall
orientation of the helices (Table 1).
The FIC domain of HYPE shares general features of other FIC
domain structures as shown by an overlay with the FIC domain
from H. pylori and IbpAFic2 (Figure 2B). As defined by Pfam,
the common core of the FIC domain includes four a helices
(a1–4) (Finn et al., 2010). Additional helices at the N- and C-
termini of the core are present in most FIC protein structures
and show considerable variation in location and orientation.
Several such additional a helices are present in HYPE, three at
the N terminus and two at the C terminus. Within the FIC core,
two features are present in most known structures: (1) the cata-
lytic loop and (2) the flap (Garcia-Pino et al., 2014) (Figure 2B).
Table 1. Data Collection and Refinement Statistics
HYPE Construct/Cofactor
Apo E234G-APCPP E234G-ATP E234G-ADP WT-ADP
Synchrotron Diamond I24 Diamond I03 Soleil home source ESRF-ID23-1
Strategy line scan line scan standard standard standard
Resolution (A˚) 2.48A (2.61–2.48) 2.98 (3.06–2.98) 2.7 (2.84–2.7) 2.54 (2.65–2.54) 2.98 (3.25–2.98)
Rmrg 0.088 (0.854) 0.159 (0.496) 0.084 (0.57) 0.12 (0.814) 0.197 (0.41)
Mn (I/sd) 6.1 (1.0) 4.4 (1.7) 7.1 (1.7) 6.5 (0.9) 11.8 (5.3)
Comp (%) 97.7 (97.7) 94.7 (94.7) 98.1 (92.2) 98.7 (98.7) 84.0 (43.5)
Mult 3.1 (3.0) 3.5 (3.1) 3.0 (3.0) 3.2 (2.5) 14.0 (7.2)
CC_Imean 0.994 (0.701) 0.981 (0.843) 0.991 (0.815) 0.994 (0.546) 0.993 (0.718)
Spg P21 P1 P21 P21 P21212
Mosaicity 0.18 0.34 0.17 0.94 0.2
Cell () 71.19, 76.81, 93.19 77.1, 83.75, 130.02 71.25, 76.11, 92.2 71.04, 76.01, 92.03 77.86, 109.08, 131.54
(A˚) 90, 108.05, 90 89.92, 89.56, 89.43 90.0, 107.28, 90.0 90.0, 107.56, 90.01 90.0, 90.0, 90.0
Wilson B (A˚2) 63.521 39.31 43.068 68.8 51.9
PHASER model 3CUC
Refinement
No. reflections 33,248 65,073 27,626 32,508 20,620
Rfac/Rfree 21.24/24.42 0.21/0.25 0.20/0.26 0.21/24 0.2/0.26
No. atoms
Protein 5,053 20,412 5,051 5,062 5,172
Ligand 216 1,080 324 225 244
Water 158 824 198 145 156
B factors (A˚2)
Protein 81.3 61.83 70.8 64.55 32.5
Ligand 101.25 72.6 69.65 21.92 38.55
Water 62.985 37.3 59.11 48.87 21.56
Root-mean-square deviations
Bond lengths (A˚) 0.01 0.01 0.01 0.01 0.01
Bond angles () 1.16 1.08 1.05 1.2 1.16
Structure
Structure of HYPEThe catalytic loop in HYPE proteins, commonly positioned be-
tween the core a helices 3 and 4, shares the general signature
motif of FIC domains, HxFx(D/E)(A/G)N(G/K)R, represented in
HYPE by the sequence HPF(I/V)DGNGRT(S/A)R. The critical
His residue within the catalytic motif corresponds to His 363 in
the human HYPE (Figure S1). The second feature, the flap, is
either a b-hairpin or a loop preceding helix a2; this structure
appears to facilitate positioning of the target residue. In HYPE,
a loop region between residues 311–324 corresponds to the
flap-like structure. A recent exhaustive bioinformatics analysis
coupled with homology modeling of FIC domains revealed
another feature, an inhibitory motif outside the FIC core (Engel
et al., 2012). The inhibitory helix (ainh) contains a common inhib-
itory signature, (S/T)xxxE(G/N), conserved in HYPE proteins as
(T/S)V(A/G)IEN, with the critical Glu residue corresponding to
Glu 234 in the human protein (Figures 2B and S1). However,
some FIC domain proteins lack ainh, as illustrated here for
IbpA2FIc (Figure 2B); the highly similar Vop S protein also lacks
ainh (Engel et al., 2012).
The FIC domain has been predicted to be present in many
(about 3,000) proteins encoded by all genomes sequenced to
date, varying in length and domain organization (Kinch et al.,Stru2009). The crystal structure of HYPE (Figures 1 and S2A) reveals
the interaction surfaces between the FIC domain and the linker a
helix, and between the FIC domain and a helix 2 of the second
TPR-motif (TPR2 a2). The FIC domain interaction surface with
the linker is more extensive (z684 A˚2) and contributes residues
mainly from the post B a helix; however, residues from a3 and
apost A linker (flanking the catalytic loop), as well as one residue
from ainh, are also involved. The contact area between the FIC
domain and TPR2 a2 is smaller (z215 A˚2) and restricted to the
apost A and apost B helices of the FIC domain. The N-terminal
portion of the linker also interacts with the TPR2 motif (with
residues within TPR2 a1 and a2 helices). Overall, these intramo-
lecular interactions likely result in restricted flexibility for the
molecule, where the catalytic site of the FIC domain and TPR-
motifs are accessible to cofactor binding and protein-protein
interactions, respectively (Figures 1 and S3).
Dimerization of HYPE
The crystal structure of HYPE revealed asymmetric dimers with
an interaction surface formed exclusively of FIC domain contacts
(Figure 3A). There are two distinct areas of interactions (Fig-
ure 3B). The first encompasses apre A helix, apre B helix, andcture 22, 1831–1843, December 2, 2014 ª2014 The Authors 1833
AB
Figure 2. Features of TPR and FIC Domains
(A) Schematic diagrams (top) and structural comparison (bottom) of TPR domain fromHYPEwith P4H TPRdomain (left, 1TJC) and PP5 TPRdomain (right, 2BUG).
Position of a peptide from Hsp 90, binding to the TPR groove in PP5 is also shown (right).
(B) Schematic diagrams (top) and structural comparison (bottom) of FIC domain from HYPE with H. Pylori FIC (left, 2F6S) and IbpA2Fic (right, 4ITR). Positions of
the catalytic loop (yellow), flap (purple), and inhibitory motif (red) are shown, as well as the position of ATP-cofactor from structure of E234G HYPE. FIC-domain
core (FIC-core) a helices are labeled as 1–4. The last, ainh helix from H. Pylori FIC is circularly permuted and overlays with the ainh helix from HYPE FIC. IbpAFic2
lacks an ainh helix. Pre B a helix from HYPE FIC overlays with pre A a helix from H. Pylori FIC, while post B a helix from HYPE FIC overlays with post A a helix from
IbpAFic2. See also Figure S5.
Structure
Structure of HYPE
1834 Structure 22, 1831–1843, December 2, 2014 ª2014 The Authors
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Figure 3. HYPE Dimers and the Dimer
Interface
(A) Ribbon (left) and surface (right) representation
of crystal structure of HYPE dimers. Structure of
the wild-type HYPE is shown and essentially the
same structure is obtained for E234G variant.
(B) The two interface areas, indicated in the ribbon
representation of a HYPE dimer, are shown as
insets. The amino acid residues indicated in the
first area (top inset) correspond to V252, K256,
Y250, L258, and N262; they are shown as residue
numbers in monomers (A) and (B). The amino acid
residues indicated in the second area (bottom
inset) correspond to R295, G299, Y300, and D303.
Structure
Structure of HYPEtheir linker. The second area incudes a1 helix and follow up
linker, preceding the flap. The first dimerization region is more
extensive (z450 A˚2) and involves a number a hydrogen bonds;
the second area is smaller (z375 A˚2) with weaker interactions,
likely to allow for some flexibility (Figure 3B, insets).
The TPR-motifs and the linker are not involved in dimerization,
and all TPR-motifs are exposed for ligand binding. Interestingly,
TPR-motifs from each monomer are positioned at the opposite
sides of the dimer surface (Figure 3). This arrangement precludes
cooperation of TPR repeats from two monomers and would
allow interactions with two protein partners, and thus contribute
to formation of larger complexes. TPR recognition could also be
related to selection of protein targets for PTM (see Discussion).
A further analysis of the properties of HYPE constructs in so-
lution confirmed that dimerization is not restricted to conditions
used for crystallization. Using size exclusion chromatography,
we showed that the elution profile of HYPE corresponded to
dimers, and as expected from the crystal structure, the deletion
of TPR-motifs did not disrupt dimerization (Figure 4A). However,
mutations of residues at the dimerization surface identified a sin-
gle residue replacement, L258D, sufficient to generate a HYPE
monomer (Figure 4A).
Further properties of the HYPE dimers and monomers were
analyzed by small angle X-ray scattering (SAXS) (Figures 4B
andS4). In agreement with the crystal structure, the SAXS gener-Structure 22, 1831–1843, Dated wild-type model was consistent with
it being a dimer in solution. In contrast, the
parameters generated for the L258D
HYPE variant suggest this exists as a
monomer in solution.
As discussed further below, dimeriza-
tion of HYPE results in two transmem-
brane domains per dimer of the full length
HYPE and is likely to have an impact on
the relative orientation toward membrane
structures and further restrict flexibility
(see Discussion).
FIC Domain and Cofactor Binding
There are two critical elements for the
enzyme activity of FIC proteins, these
are the catalytic loop and, for some FIC
domains, also the inhibitory helix (Fig-
ure S5). In HYPE, the conformation ofthe catalytic loop is the same as in other structurally defined
FIC enzymes (Garcia-Pino et al., 2014); a scaffold of two a heli-
ces (a3 and a4) together with the side chains of the conserved
Phe365 and Asn369 of the catalytic loop contribute to its distinct
structure. The Phe365 side chain anchors the catalytic loop to
the hydrophobic core of the enzyme, whereas the amide group
of the conserved Asn369 holds the loop through a network of
hydrogen bonds to the peptide backbone. The GNG submotif
forms an ‘‘anion hole’’. In the structure of wild-type HYPE, the
inhibitory glutamate, Glu234, from ainh is positioned in the vicin-
ity of the catalytic loop.
In addition to apo structures of HYPE variants, we have also
obtained structures with the ATP cofactor bound to an E234G
variant and with ADP bound to either the HYPE E234G variant
or to wild-type protein (Figures 5A and 5B). The positions of
the adenosine moiety, ribose ring, and phosphates from all three
structures and orientations of critical residues are generally
consistent with the previous insights from structural studies of
complexes of other FIC domains with ATP and ATP-related
ligands (Engel et al., 2012; Goepfert et al., 2013; Palanivelu
et al., 2011; Xiao et al., 2010). The adenosine moiety of the
ATP and ADP locks into a hydrophobic pocket formed between
a3, apost A and the flap loop; the side chain residues forming this
pocket are Val360 (a3), Leu403 (apost A), and Val316 (flap).
There is also direct coordination by one residue, Asn407 (Figuresecember 2, 2014 ª2014 The Authors 1835




























78.9 4.1 ± 0.01  12.9 ± 0.5 1.049 
39.4 2.7 ± 0.02  8.0 ± 0.5 2.484 
Figure 4. Properties of HYPE Dimers in Solution
(A) Analytical gel filtration of HYPE constructs. HYPE variant (103–434), con-
taining TPR-motifs, linker, and FIC domain, is shown in red. HYPE (172–445),
containing the linker helix and FIC domain, is shown in blue. The HYPE
(103–445) L258D mutant is shown in black.
(B) Selected parameters of soluble HYPE constructs from analyzed SAXS
data. See also Figure S4.
Structure
Structure of HYPE5B and 5C). The GNG anion hole (residues 368–370) accommo-
dates the a-phosphate of the nucleotide, mainly through direct
hydrogen bonds to the polypeptide backbone. A Mg2+ ion is
visible in the E234G variant of HYPE; it bridges the a- and
b-phosphates and is coordinated by the conserved Asp367
side chain. The conserved arginine at the C-terminal side of
the FIC catalytic loop, Arg374, forms hydrogen bonds with the
ribose ring and is also critical for binding of the g-phosphate.
The position of the inhibitory glutamate (Glu234) in the structure
of wild-type HYPE is consistent with its role in competing with
the Arg374/g-phospate interaction (Figure 5A). Interestingly,
there is a difference in side chain orientation of Glu234 in apo
and ADP bound structures of the wild-type HYPE that shows
that this side chain can also affect ADP binding and that is suffi-
ciently flexible to accommodate bound ADP (Figure 5A). The po-
sition of clearly visible a- and b-phosphates in all three structures
is the same, with the a-phosphate present in an orientation
compatible with the AMPylation reaction (Figure 5A). This is
consistent with previous findings that the engagement of b-
and g-phosphates of ATP or AMPPNP to wild-type FIC proteins
is obstructed by the inhibitory glutamate, resulting in a nonpro-
ductive orientation of the a-phosphate, while in all structures
obtained for glutamate substitutions or deletions, the position
of ATP is the same, with a productive orientation of the a-phos-
phate (Engel et al., 2012; Goepfert et al., 2013). Correct posi-
tioning of the a-phosphate in the wild-type HYPE/ADP complex
shows that also in the case of HYPE, the g-phosphate, and
to some extent b-phosphate, could preclude efficient and/or
enzymatically correct ATP binding to the wild-type protein.1836 Structure 22, 1831–1843, December 2, 2014 ª2014 The AuthorFor the transfer reaction catalyzed by FIC enzymes, the pro-
ductive binding of the nucleotide is achieved by the correct posi-
tioning of the conserved Arg374; this in turn allows insertion of
the attacking group of the target, facilitated by the flap structure.
The conserved His363 in HYPE is well positioned to compete
with the catalytic motif that would result in a favorable interaction
with a high-energy pyrophosphate bond of the nucleotide to act
as a general base in the catalysis, allowing the transfer of the
AMP moiety (Figures 5B and 5C). The structure of HYPE
E234G with the nonhydrolysable ATP analog, APCPP, shows a
different position of the a-phosphate that would be incompatible
with catalysis (Figure S6), suggesting that APCPP is not a phys-
iological ATP mimic in this case.
Based on the limited coordination of adenosine in the hydro-
phobic pocket, it is likely that other nucleotide phosphates or
other cofactors can bind to this site. Measurements of binding
of a range of ligands to the E234G variant (172–434) using ther-
mal shift analysis excluded phosphocholine as a possible
cofactor (utilized by some FIC-domain proteins such as AnkX)
(no shift in Tm, data not shown) and showed similar binding of
ATP and guanosine-5’-triphosphate, and a less strong binding
of cytidine triphosphate and uridine triphosphate (Figure 6A).
Interestingly, binding of ADP was stronger than that of ATP. A
possible reason could be that ATP adopts a less favorable
conformation within the binding pocket compared to free ATP,
a constraint that would not apply to ADP. The measurement of
the dissociation constant (KD) of ADP binding to the E234G
variant determined by isothermal titration calorimetry (ITC) was
160 nM (Figure 6B). Wild-type HYPE also bound ADP (as the
only ligand, Figure 6A), but with a considerably lower affinity
and KD of 1.5 mM (Figure 6B), possibly owing to electrostatic
repulsion by the side chain of by Glu234. Binding of ATP to
wild-type HYPE could not be detected using these methods.
These findings are in general agreement with the structural
data and with the previously proposed role of the inhibitory Glu
in obstructing correct engagement of the g and b phosphates
of ATP.
Enzyme Activity of HYPE Variants and Possible Protein
Targets
The structures of the HYPE variants with ATP and ADP, direct
binding measurements, and earlier work suggest that HYPE
can function in protein AMPylation. However, the basal activity
of the wild-type HYPE is probably lower when compared to the
E234G variant. It has been previously documented that the pro-
posed intramolecular inhibition in several FIC domains (Engel
et al., 2012) can be reversed by replacing the critical inhibitory
Glu residue by Gly, using autoAMPylation as a readout (Goepfert
et al., 2013). Regardless of the physiological relevance of this
replacement, conservation of the reaction mechanism (Garcia-
Pino et al., 2014) would allow application of this strategy for
the analysis of structure-function relationship. Using a chemo-
enzymatic tagging and a Yn-6-ATP in vitro probe (Figure S7)
(Heal et al., 2012) (compatible with the AMPylation reaction,
see Grammel et al., 2011), we were able to show by fast in-gel
fluorescence readout, that HYPE can autoAMPylate (Figure 7A).
Furthermore, basal activity of the wild-type HYPEwas drastically
boosted by the E234G mutation. In contrast, mutations of the






































Figure 5. Structures of HYPE Variants with Bound ADP and ATP
(A) Binding pocket for ATP and ADP in E234G and wild-type (WT) variants; density of the cofactors, catalytic His 363, and g-phosphate coordinating Arg 374 are
indicated. For WT/ADP, two conformations (more abundant conf. 1 and conf. 2) of the side chain Glu 234 are indicated. Electron density around the adenosine
part of the ligand was poor, and so it is not shown for clarity.
(B) Overlay of ATP and ADP in the binding pocket of E234G variant; some of the key residues are labeled. See also Figure S6.
(C) Coordination of ATP by E234G variant, represented as a LigPlot+ diagram.
Structure
Structure of HYPEof the E234G variant) abolished the enzyme activity (both values
were about 4%–6% of control), consistent with the conserved
reaction mechanism.
We used this autoAMPylation assay to test the functional im-
plications of interdomain interactions on enzyme activity of the
FIC domain. Removal of the TPR-motifs (residues 103–172)
maintained a stable protein; however, further deletions from
the N terminus up to residue 215, that removed the a helix linker,
resulted in a highly unstable protein that was insoluble as a single
entity. A comparison of constructs that incorporate (residues
103a434, E234G) and lack TPR-motifs (residues 172a445,
E234G) show a clear reduction in autoAMPylation in the absence
of TPR-motifs (Figure 7B). We also excluded the possibility thatStruthis reduction is due to the removal of sites of autoAMPylation
that could be present in TPR-motifs. Using a fusion protein of
the HYPE variant that is catalytically inactive (SUMO-tag,
H363A), the AMPylation of this protein was also reduced to
less than 10% when using an E234G construct lacking TPR-
motifs. Furthermore, the replacement of potential AMPylation
sites in the TPR-motifs (T168A, S170A, and Y172F) did not
have an effect on the overall level of autoAMPylation (values
within ± 10% of control). Together with structures of the HYPE
constructs, this analysis of enzyme activity shows that the FIC
domain interactions with the a helix linker and TPR-motifs
are required for protein stability and efficient catalytic activity
of the FIC domain.cture 22, 1831–1843, December 2, 2014 ª2014 The Authors 1837
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Figure 6. Cofactor Binding
(A) Differential scanning fluorimetry (thermal shift) analysis of HYPE E234G (left) andWT (right) in the absence (control) and presence of indicated compounds. The
data are representative for two independent experiments with the same relative difference in Tm.
(B) Binding of ADP to the E234G (E234G, residues 103–445) (left) and WT variant (WT, residues 103–445) (right) was measured by ITC. The indicated errors
represent the error of the fit.
Structure
Structure of HYPEAutoAMPylation activity of the FIC domain appears also to be
affected by replacement of residues involved in dimerization or in
the vicinity of the dimerization surface (Figure 7C). The activity of
the purified L258D variant, which is a monomer in solution, was
greatly reduced. Interestingly, some other mutations close to the
dimerization surface, not sufficient to disrupt dimerization, also
had an impact on autoAMPylation (Figure 7C, top). This suggests
that the reduced enzyme activity of the L258D variant may not
simply result from the generation of a monomeric form of
HYPE. Additionally, the impact of the L258D mutation on au-1838 Structure 22, 1831–1843, December 2, 2014 ª2014 The AuthortoAMPylation of the E234G, full-length variant, was observed
in a cellular setting (Figure 7C, bottom).
While the measurements of autoAMPylation provide some in-
sights into structure-function relationships, the physiological
significance of autoAMPylation remains unclear. Furthermore,
a cellular substrate of HYPE has not been defined (Garcia-
Pino et al., 2014). In our initial experiments addressing this
question, we used a Yn-6-ATP-based assay in vitro to compare
proteins in cell extract that become AMPylated by HYPE, and
by one of the well-studied FIC domain proteins VopS from Vibrios
A B
C D
Figure 7. AMPylation Activity of HYPE
(A) Effect of E234G mutation on autoAMPylation of HYPE was analyzed by Yn-6-ATP-based assay, using WT and E234G variant (E234G) of HYPE (residues
103–434). For the control lane (C), HYPE protein was not included. Inset shows protein bands resolved by SDS-PAGE and Coomassie stained (bottom) and
corresponding in-gel fluorescence (top). Fluorescence corresponding to autoAMPylation was quantified using ImageJ.
(B) Effect of deletion of TPR-motifs on AMPylation activity of HYPE was analyzed as in (A), using E234G (E234G, residues103–445) and E234G/DTPR (E234G,
residues 172–445) variants of HYPE. In addition to autoAMPylation, AMPylation of H363A HYPE, containing SUMO-tag (SUMO-H363A, residues 103–445) was
also analyzed. Left panel shows protein bands (bottom) and corresponding fluorescence (top). Lanes 1–6 correspond to; control without enzyme (1), SUMO-
H363A (2), E234G (3), E324G/DTPR (4), E234G with SUMO-H363A (5), and E234G/DTPR with SUMO-H363A (6). Positions of AMPylated bands are indicated (.).
(C) Top panel shows effect of L258D, N262D, I265D, and R295Emutations on autoAMPylation of E234GHYPE (E234G, residues 172–445), analyzed as described
in (A); inset shows protein bands (bottom) and corresponding fluorescence (top). Bottom panels show western blots of the full-length HYPE variants E234A and
E234A/L258A, expressed in HEK293T cells, performed using either anti-His tag (aHis) (left) or anti-AMPThr (aAMP) antibodies (right).
(D) AMPylation of cellular proteins in vitro was performed using purified HYPE E234G (E234G, residues 103–445) and VopS in the presence of the cell lysate from
HeLa cells. The cell lysate without added enzyme was used as a control (C). Left panel shows protein bands and the right panel corresponding fluorescence;
autoAMPylation of HYPE E234G and VopS are indicated (.), as well as AMPylation in the area corresponding to mobility of small GTPases (]).
The indicated error bars in (A)–(C) represent SD from two experiments. See also Figure S7.
Structure
Structure of HYPEparahaemolyticus that lacks autoinhibition (Figure 7D). As
expected, the main AMPylation targets of VopS are in agree-
ment with molecular sizes corresponding to Rho family
GTPases. In contrast, small GTPases did not seem to be tar-
geted by E234G (or wild-type) HYPE and, in addition to strong
autoAMPylation, several other proteins appear to be AMPylated
by the E234G variant. These findings suggest that HYPE may
have a range of interacting proteins and targets in cells, and
that further development of cell permeable cofactor analogs
allowing for profiling in live cells could provide a suitable routeStruto identifying targets of HYPE presented in its physiologically
relevant subcellular localization.
DISCUSSION
Recent findings that protein AMPylation is a novel PTMoccurring
in eukaryotic cells, highlighted the need to better define its role
beyond bacterial infection, where FIC-domain containing en-
zymes are of bacterial origin (Yarbrough and Orth, 2009). We









Figure 8. AModel Depicting HYPEDimers in
the Membrane Vicinity
Properties of HYPE structure are summarized
by surface representation of a dimer. A HYPE
dimer is featured relative to the plane of a cellular
membrane, taking into consideration that the 20
amino acid long transmembrane domains would
be imbedded into the membrane and that flexible
(largely unstructured) linkers of about 60 resi-
dues connect transmembrane domains and TPR-
motifs.
Structure
Structure of HYPEAMPylator encoded by eukaryotic genomes, and further analyze
and discuss the functional implications of its distinct features.
Eukaryotic HYPE proteins are membrane proteins that
uniquely combine one transmembrane helix, two TPR-motifs,
and the FIC domain. The structure of the large portion of this
protein, including the TPR-motifs, linker region, and FIC domain,
summarized in Figure 8, shows that intramolecular interactions
result in a rigid arrangement that is extended further by dimeriza-
tion. TPR-motifs are positioned so that the active site opening
in the FIC domain is exposed. Also, intramolecular interactions
leave TPR-motifs free to engage in other protein-protein inter-
actions. There are two TPR-motifs of each monomer that are
placed at the opposite side of the dimer surface, precluding
formation of a larger platform of TPR repeats.
The overall structure of HYPE shows some distinct properties
when compared to other proteins that harbor FIC domains or
with proteins where TPR domains are combined with other
enzyme activities. It appears that to date, FIC-mediated dimer-
ization has not been observed for bacterial effectors, which are
in most cases monomeric in solution (Garcia-Pino et al., 2014).
An interaction of the FIC domain with a defined domain structure
has been described only in one other protein, AnkX, where
a similar repeat domain, ankyrin repeat, interacts with the FIC
domain so that surfaces usually involved in interactions with
other binding partners are involved in intramolecular interactions
(Campanacci et al., 2013); this is clearly not the case for HYPE
(Figures 1 and S3). The relative orientation of the FIC domain
and TPR-motifs in HYPE is also distinct from those observed in
PP5 (Figure S3) or Cyp40, two examples where the structures
for the full-length TPR-proteins have been determined (Allan
and Ratajczak, 2011). In PP5, the TPR domain engages with
the catalytic channel of the phosphatase domain, restricting ac-
cess to the catalytic site, while in Cyp40 the two domains (TPR
domain and peptidyl prolyl isomerase domain) are completely in-
dependent (Taylor et al., 2001; Yang et al., 2005). Positions
observed in HYPE are intermediate between these two exam-
ples; there are clear interaction surfaces, centered on the C-ter-
minal a helix of the TPR domain, leaving both the FIC active site
and grooves of TPR-motifs exposed (Figures 1 and S3).
TPR repeats (usually three or more) have been predicted to
occur in a large number of proteins (about 5,000), and many1840 Structure 22, 1831–1843, December 2, 2014 ª2014 The Authorshave been suggested to act as scaffolds
for the assembly of multiprotein com-
plexes, such as protein folding com-
plexes, anaphase promoting complex, or
the peroxisomal import receptor complex(Allan and Ratajczak, 2011; Blatch and La¨ssle, 1999; D’Andrea
and Regan, 2003; Zeytuni and Zarivach, 2012). In addition to
adaptor proteins (such as Hop), some TPR proteins that contain
enzyme domains (including PP5 and Cyp40) have been sug-
gested to be part of larger complexes. Although this remains an
interesting possibility for HYPE, information available for its func-
tion is limited, and there is no clear evidence that it is incorporated
into larger complexes. Another possibility is that the TPR-motifs
have a role in the recognition of a protein target. TPR-motifs pre-
sent in the a subunit of tetrameric (a2b2) propyl P4H are mainly
involved in substrate (collagen) recognition and have an essential
role in collagen synthesis (Pekkala et al., 2004). Furthermore,
among the FIC domain proteins, the target binding sites are not
conserved and each recognition site is largely influenced by
unique target-recognition elements, additional to the FIC a-heli-
cal core. For example, in IbpAFic2, an additional ‘‘arm domain’’
provides a large set of unique contacts with the target. This is
also an all a-helical lobe domain that protrudes N-terminally
from the FIC domain (Xiao et al., 2010). Interestingly, the relative
orientation of the armdomain and theFICcore in IbpAFic2 is such
that the active site is exposed, as observed for HYPE (Figure S3).
So far, the best-defined targets for FIC–containing proteins
are GTPases: Rho GTPases are AMPylated by VopS and IbpA;
Rab1 and Rab35 are phosphocholinated by AnkX; and EF-Tu
is phosphorylated by Doc; a different example is provided by
AvrAC, that targets two kinases (BIK1 and RIPK) by UMPylation
(Garcia-Pino et al., 2014). In all these cases, substrate recogni-
tion is very specific, and the effect on target function is inhibitory.
However, these are all bacterial effectors and targets, and
the function of HYPE could be different. Our initial data show
clear differences between VopS recognition of Rho GTPases
and distinct, potential substrate targets of HYPE (Figure 7D).
Assuming the involvement of TPR-motifs in substrate recogni-
tion, it has been documented that these motifs have a range
of interaction partners. Among TPR-motifs, only the TPRs from
p67phox bind a GTPase, namely Rac. The recognition surface
is, however, not placed in the TPR groove, but, instead, the bind-
ing occurs almost exclusively to the b hairpin insertion element,
unique to p67phox (Lapouge et al., 2000).
Our data describing the cofactor binding, where binding of
ATP to wild-type HYPE is obstructed by the conserved glutamic
Structure
Structure of HYPEacid residue (Figure 5), raise two possibilities. An explanation is
based on a concept that the inhibitory a helix and the critical glu-
tamic acid residue obstructing binding of the g-phosphate of
ATP can be removed in the course of a physiologically relevant
activation process. This argument is based on a comprehen-
sive analysis of FIC-domain proteins that has identified the
conserved inhibitory motif and its coevolution with the
conserved FIC motif and putative AMPylation function (Engel
et al., 2012). The cofactor binding pockets of FIC domain pro-
teins DOC and AnkX involved in phosphorylation and phospho-
cholination, respectively, are clearly different from an ADP or
ATP binding site in HYPE, and several other proteins with the ca-
nonical FIC motif (Engel et al., 2012; Goepfert et al., 2013; Pala-
nivelu et al., 2011). Cofactors are placed in a different orientation,
and elements specific for DOC or AnkX facilitate their binding
and/or preclude orientation observed in HYPE (Campanacci
et al., 2013; Castro-Roa et al., 2013). It has also been observed
that wild-type HYPE has low basal levels of AMPylation that are
enhanced rather than created by the E234G replacement (Worby
et al., 2009; Mattoo et al., 2011; Engel et al., 2012; Yu et al.,
2014). However, one important unresolved question with respect
to autoinhibition is related to the mechanism that would over-
come this inhibitory constraint, leading to activation. The struc-
ture of HYPE shows that ainh is held in place by the rest of the
structure, and weakening the interaction of ainh with the FIC
active site could require significant conformational changes
to move the glutamate away from the active site. Therefore,
an explanation that the glutamate discriminating against ATP
evolved to preclude ATP binding in favor of another cofactor
(Campanacci et al., 2013) provides a plausible alternative. While
further analysis of a physiologically relevant new cofactor for
HYPE would require other experimental approaches, binding
studies shown here (Figure 6) suggest that compounds related
to nucleotide bisphosphates could be relevant candidates.
Unlike most other FIC domain proteins, HYPE contains a
transmembrane helix and is expected to function in membrane
proximity. A recent study on Drosophila has suggested that
HYPE is localized at the endoplasmic reticulum rather than the
plasmamembrane (Rahman et al., 2012); our initial data for local-
ization of human HYPE in transfected cells are consistent with
this finding (data not shown). Because of the dimer structure of
HYPE, and, consequently, two anchor points with cellular mem-
branes per dimer, it is likely that the positioning with respect to
the membrane could be less flexible, with restricted orientation
(Figure 8). This, in turn, could influence protein-protein interac-
tions and contribute to a more precise assembly of potential,
larger complexes or influence target selection.
New insights obtained by structural and functional character-
ization of HYPE, together with methodologies that may allow
discovery of protein targets in cells, provide important steps to-
ward further elucidation of physiological roles of HYPE and the
significance of posttranslational modifications mediated by this
unique eukaryotic protein.EXPERIMENTAL PROCEDURES
Constructs
Full length constructs for mammalian expression were cloned into pcDNA-
Dest40 (Life Technologies) in frame with a C-terminal mVENUS fluorescentStrutag and a HIS-tag. Constructs for bacterial expression were cloned into
pOPINS (Oxford Protein Production Facility) with boundaries 103–434, 103–
445, and 172–445. Point mutations E234G, H363A, T168A, S170A, Y172F,
L258D, N262D, I265D, R295E, E259G, E263G, and D367G were introduced
in constructs for bacterial expression or, when specified, also in mammalian
expression vector. Combinations of point mutations are indicated for specific
constructs.
Expression and Purification
The E. coli strain C41(DE3) (Lucigen) was used for expression of most con-
structs. Transformed cells were grown in 23YT media containing 50 mg/ml
kanamycin at 37C until an optical density600 of between 0.5 and 0.8. The tem-
perature was decreased to 20C and expression was induced through the
addition of 0.1 mM isopropyl b-D-1-thiogalactopyranoside for 16 hr. Cell lysis
was performed on frozen pellets using 25 mM Tris.Cl, 250 mM NaCl, 40 mM
Imidazole, and 5 mM Benzamidine.HCl, pH 8.0 with the addition of 0.1 mg/
ml lysozyme and 1% (v/v) Triton X-100 at 4C. Purification was performed
using Ni2+ chelating chromatography, followed by cleavage of the His-
SUMO tag through the addition of Ulp1 protease. Subsequently, Q-sepharose
ion-exchange chromatography and gel filtration chromatography were per-
formed, the protein concentrated to 20 mg/ml and aliquots snap frozen in
liquid N2, and stored at80C. Transfection of full-length constructs into Free-
style human embryonic kidney (HEK)293F mammalian cells was performed
according to manufacturers instructions (Life Technologies).
Crystallography
Apo, wild-type HYPE, was concentrated to 9 mg/ml prior to crystallization via
vapor diffusion with 20% polyethylene glycol 3,350, 200 mM Na K Tartrate,
and 100mM Bis-Tris Propane pH 7.5 as mother liquor mixed in a 2:1 ratio,
plates were then stored at 16C for crystal growth. Mutant E234G HYPE
was crystallized in the same condition. Mutant crystals of a higher quality
were achieved with the addition of 10 mM Yn6ATP analog. Initial diffraction
experiments revealed no analog in the active site, however. Following crystal-
lization, all crystals were soaked in a cryoprotectant containing mother liquor
with a 50% saturated solution of sucrose. Mutant crystals were also soaked
with 10mM ATP or ADP alongside 10mM MgCl2.
Data were collected using synchrotron radiation from Diamond Light
Source; using line scans to maximize data collection time for apo and APCPP
data sets. The ATP data set was collected at Synchrotron Soleil and the ADP
data set using a Rigaku home source.
All data sets were processed using the integration program XDS (Kabsch,
2010) with further processing using the CCP4 program Aimless (Winn et al.,
2011). Molecular replacement was carried out using the program PHASER
(McCoy et al., 2007; Winn et al., 2011). The search model was created from
the FIC domain structure 3CUC from the Protein Data Bank (PDB), from
Bacterioedes thetaiotaomicron, paired back to shared atoms using the pro-
gram CHAINSAW (Stein, 2008; Winn et al., 2011). There were two molecules
that were found which were rebuilt using the program COOT (Emsley et al.,
2010; Winn et al., 2011). N-terminal TPR-motifs were initially not readily visible.
To search for the expected helical domains, real space searching was applied
with the program FFEAR (Cowtan, 1998; Winn et al., 2011) using a nine
residues polyalanine helix as the search model. This resulted in multiple hits
together close to the two FIC domains. Careful rebuilding and extension of
this region with subsequent refinement using the BUSTER program (Bricogne
et al., 2011) produced the long linker helix followed by the N-terminal TPR-
motifs. Finally, water molecules and ligands were built into the structure, and
the final structure was validated using the Molprobity server (Chen et al.,
2010). LigPlot+ (Laskowski and Swindells, 2011) was used for generation of
ligand binding diagrams.
ITC
ITC measurements were performed as described previously (Bunney et al.,
2009, 2012). Heats of interaction were measured on a VP-ITC system (Micro-
cal) with a cell volume of 1.458 ml. HYPE molecules were dialyzed for 16 hr in
ITC buffer (25 mM Tris.Cl, 150 mM NaCl, 50 mM MgCl2, and 1 mM TCEP, pH
8.0). HYPEwas loaded in the sample cell at 100 mMand titrated with ADP in the
syringe (1mM). The titrations were performedwhile sampleswere being stirred
at 260 revolutions per minute at 20C. A total of 25 injections were carried out,cture 22, 1831–1843, December 2, 2014 ª2014 The Authors 1841
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Structure of HYPEwith 10 ml injected each time (except the first injection, when 3 ml was injected),
and a 4 min interval between each injection to allow the baseline to stabilize.
The data were fitted with a single site model to calculate the number of binding
sites (n), the binding constant (Ka), the change in enthalpy (DHo), and change in
entropy (DS) using Origin software (Microcal, 2004).
Differential Scanning Fluorimetry
Ligand binding experiments were performed on a Stratagene MX3005P
machine (Agilent Technologies) running MxPro qPCR software (Agilent Tech-
nologies, 2009). Experiments were carried out in 96-well real-time PCR plates
with 20 ml samples (duplicates) containing 2 mM protein, 200 mM ligand (or
vehicle), 5 mM MgCl2, and 10 3 SYPRO Orange dye in 25 mM Tris.Cl,
150 mM NaCl, and 1 mM TCEP, pH 8.0. Fluorescence of the SYPRO Orange
dye was monitored in each well over 25–95C. Curves were analyzed in MS
Excel (Microsoft, 2011).
Additional experimental procedures describing western blotting of full-
length HYPE constructs expressed in HEK293F cells, SAXS, and AMPylation
assays are included in Supplemental Experimental Procedures.
ACCESSION NUMBERS
The crystal structures of HYPE have been deposited in the PDB with the
accession codes, 4U04 (apo), 4U07 (E234G variant/ATP bound), 4U0S
(E234G variant/ATD bound), 4U0U (wild type/ATD bound), and 4U0Z (E234G
variant/APCPP bound).
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